DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons.

[1]  S. Algeri,et al.  A Rapid and Simple Method for the Determination of Picogram Levels of 3‐Methoxytyramine in Brain Tissue Using Liquid Chromatography with Electrochemical Detection , 1981, Journal of neurochemistry.

[2]  A. Cho,et al.  The effects of xylamine, a nitrogen mustard on [3H]norepinephrine accumulation in rabbit aorta. , 1980, The Journal of pharmacology and experimental therapeutics.

[3]  L. M. Zieher,et al.  Neurotoxicity of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP 4) on noradrenergic neurons is mimicked by its cyclic aziridinium derivative. , 1980, European journal of pharmacology.

[4]  L. M. Zieher,et al.  DSP-4: A novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats , 1980, Brain Research.

[5]  G Jonsson,et al.  Chemical neurotoxins as denervation tools in neurobiology. , 1980, Annual review of neuroscience.

[6]  F. Wiesel,et al.  Developmental plasticity of central noradrenaline neurons after neonatal damage--changes in transmitter functions. , 1979, Journal of neurobiology.

[7]  A. Cho,et al.  Inhibition of uptake of catecholamines by benzylamine derivatives. , 1979, Journal of medicinal chemistry.

[8]  S. Cohen,et al.  Differential solubilities in subregions of the membrane: a nonsteric mechanism of drug specificity. , 1979, Journal of medicinal chemistry.

[9]  F E Bloom,et al.  Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. , 1979, Annual review of neuroscience.

[10]  G. Jonsson,et al.  2810 – A NEW NEUROTOXIC COMPOUND AS DENERVATION TOOL FOR NORADRENALINE NEURONS , 1978 .

[11]  S. Snyder,et al.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. , 1977, Molecular pharmacology.

[12]  S. Ross,et al.  (Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake. , 2009, Acta pharmacologica et toxicologica.

[13]  S. Ross.  LONG‐TERM EFFECTS OF N‐2‐CHLOROETHYL‐N‐ETHYL‐2‐BROMOBENZYLAMINE HYDROCHLORIDE ON NORADRENERGIC NEURONES IN THE RAT BRAIN AND HEART , 1976 .

[14]  A. Oke,et al.  Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping. , 1976, Life sciences.

[15]  Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment. , 1976, Medical biology.

[16]  S. Snyder,et al.  Beta adrenergic receptor binding in membrane preparations from mammalian brain. , 1976, Molecular pharmacology.

[17]  S. Ross,et al.  On the long‐lasting inhibitory effect of N‐(2‐chloroethyl)‐N‐ethyl‐2‐bromobenzylamine (DSP 4) on the active uptake of noradrenaline , 1976, The Journal of pharmacy and pharmacology.

[18]  K. Fuxe,et al.  CHANGES IN THE DEVELOPMENT OF CENTRAL NOR ADRENALINE NEURONES FOLLOWING NEONATAL ADMINISTRATION OF 6‐HYDROXYDOPAMINE 1 , 1974, Journal of neurochemistry.

[19]  S. Ross,et al.  Cyclizing compounds. I. Tertiary N-(2-bromobenzyl)-N-haloalkylamines with adrenergic blocking action. , 1973, Acta pharmaceutica Suecica.

[20]  A. Björklund,et al.  Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurons in the rat CNS. , 1973, Acta physiologica Scandinavica. Supplementum.

[21]  C. Sachs,et al.  NEUROCHEMICAL PROPERTIES OF ADRENERGIC NERVES REGENERATED AFTER 6‐HYDROXYDOPAMINE , 1972, Journal of neurochemistry.

[22]  A. Björklund,et al.  Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine. , 1971, Acta physiologica Scandinavica. Supplementum.

[23]  G. Jonsson.  Quantitation of fluorescence of biogenic monoamines demonstrated with the formaldehyde flourescence method. , 1971, Progress in histochemistry and cytochemistry.

[24]  C. Sachs,et al.  Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons. , 1970, European journal of pharmacology.

[25]  T. Hökfelt,et al.  Fluorescence Microscopy in Neuroanatomy , 1970 .

[26]  U. Ungerstedt,et al.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.

[27]  C. Sachs,et al.  Degeneration of adrenergic nerves produced by 6-hydroxydopamine. , 1968, European journal of pharmacology.

[28]  G. Jonsson,et al.  THE FORMALDEHYDE FLUORESCENCE METHOD FOR THE HISTOCHEMICAL DEMONSTRATION OF BIOGENIC MONOAMINES A REVIEW ON THE METHODOLOGY , 1967 .

[29]  B. Falck,et al.  Cellular localization of brain monoamines. , 1962, Acta physiologica Scandinavica. Supplementum.

[30]  G. L. Miller,et al.  Protein determination for large numbers of samples. , 1959 .

[31]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.